US2011165272A1PendingUtilityA1
Antiallergic composition
Est. expiryMar 3, 2025(expired)· nominal 20-yr term from priority
A61P 37/06A61P 37/08A61P 17/00A61K 8/9789A23L 33/105A61Q 19/00A61K 2800/75A61K 8/602A61K 31/7048A61K 36/3486
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An antiallergic composition that is moderate for the human body and skin, and has reduced side-effects that comprises a cold-water extract from hop tissue or flavonoid glucosides separated from the cold-water extract from hop tissue.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . An isolated or purified composition comprising a cold-water extract of hop tissue.
18 . The composition according to claim 17 , wherein the hop tissue is beer brewing hop tissue.
19 . The composition according to claim 17 , wherein the hop tissue is from hop stems, cones or leaves.
20 . The composition according to claim 17 , wherein the hop tissue is a ground product of dried bract.
21 . The composition according to claim 17 , wherein the hop tissue is a ground product of dried cones from which at least a portion including lupulin and smaller components has been removed.
22 . The composition according to claim 21 , wherein the ground product of dried cones is a ground product of frozen dried cones.
23 . The composition according to claim 17 , wherein the hop tissue is hop residue obtained by removing at least a portion of the substances that are extracted by organic solvent extraction or supercritical fluid extraction from dried cones.
24 . The composition according to claim 17 , wherein the cold-water extract contains flavonoid glucosides.
25 . The composition comprising flavonoid glucosides separated from a cold-water extract of hop tissue.
26 . The composition according to claim 25 , wherein the flavonoid glucosides are flavonol glucosides.
27 . The composition according to claim 26 , which contains kaempferol glucosides as the flavonol glucosides.
28 . The composition according to claim 27 , wherein the kaempferol glucosides are one or more selected from the group consisting of kaempferol rutinoside, astragalin and kaempferol malonylglucoside.
29 . The composition according to claim 28 which further comprises quercetin malonylglucosides as the flavonol glucosides.
30 . The composition of claim 17 wherein the cold-water extract has been produced using cold water between 0° C. and 50° C.
31 . The composition of claim 17 wherein the cold-water extract has been produced using cold water between 0° C. and 30° C.
32 . The composition of claim 17 wherein the cold-water extract has been produced using cold water between 0° C. and 10° C.
33 . The composition of claim 17 wherein the cold-water extract has been produced using a solution of cold water and alcohol, wherein the alcohol content does not exceed 10 wt. %.
34 . A drug comprising as an active ingredient the composition according to claim 17 .
35 . A cosmetic comprising the composition according to claim 17 .
36 . A food or beverage comprising the composition according to claim 17 .
37 . A method for inhibiting release of a pharmacologically active amine or serotonin or both comprising administering the composition of claim 17 to a subject in need thereof.
38 . The method of claim 37 , wherein said subject has an allergic condition.
39 . A method of making the composition of claim 17 , comprising immersing hop tissue in water at a temperature ranging from 0° C. to 50° C. to obtain a liquid extract, and
separating the liquid extract from solid components.
40 . The method of claim 39 , comprising immersing the hop tissue in water at a temperature raging from 0° C. to 30° C.
41 . The method of claim 39 , comprising immersing the hop tissue in water at a temperature raging from 2° C. to 8° C.Join the waitlist — get patent alerts
Track US2011165272A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.